Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × nilotinib × Clear all

Status

Completed 78 Terminated 19 Unknown 11 Active not recruiting 10 Recruiting 8 Withdrawn 5 No longer available 3 Not yet recruiting 1 Approved for marketing 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Chronic-Phase 1

Interventions

Cisplatin 112 Carboplatin 110 Drug Therapy 108 Oxaliplatin 97 Bevacizumab 90 Capecitabine 89 Paclitaxel 82 Radiotherapy 80 Gemcitabine 78 Cyclophosphamide 78 pembrolizumab 77 tislelizumab 75 Specimen Handling 63 Fluorouracil 59 toripalimab 58 Docetaxel 54 Injections 52 sintilimab 51 Magnetic Resonance Spectroscopy 51 Surgical Procedures, Operative 50 130-nm albumin-bound paclitaxel 45 Biopsy 42 Leucovorin 41 fludarabine 38 Standard of Care 38 Pemetrexed 38 Immune Checkpoint Inhibitors 38 anlotinib 37 Radiosurgery 37 lenvatinib 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07091019 2025-07-29

ASC4REAL-2

Novartis

Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon ⚡